AU2016287200B2 - Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis - Google Patents

Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis Download PDF

Info

Publication number
AU2016287200B2
AU2016287200B2 AU2016287200A AU2016287200A AU2016287200B2 AU 2016287200 B2 AU2016287200 B2 AU 2016287200B2 AU 2016287200 A AU2016287200 A AU 2016287200A AU 2016287200 A AU2016287200 A AU 2016287200A AU 2016287200 B2 AU2016287200 B2 AU 2016287200B2
Authority
AU
Australia
Prior art keywords
dietetic
infection
vaginal
pharmaceutical composition
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016287200A
Other languages
English (en)
Other versions
AU2016287200A1 (en
Inventor
Beatriz Casinos Ramo
Maria Empar Chenoll Cuadros
Salvador GENOVÉS MARTINEZ
Daniel Ramon Vidal
Ángela SILVA ANGULO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring BV
Original Assignee
Ferring BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring BV filed Critical Ferring BV
Publication of AU2016287200A1 publication Critical patent/AU2016287200A1/en
Application granted granted Critical
Publication of AU2016287200B2 publication Critical patent/AU2016287200B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/02—Separating microorganisms from their culture media
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Animal Husbandry (AREA)
  • Inorganic Chemistry (AREA)
AU2016287200A 2015-06-29 2016-06-29 Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis Active AU2016287200B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15174222 2015-06-29
EPEP15174222.8 2015-06-29
PCT/EP2016/065074 WO2017001440A1 (en) 2015-06-29 2016-06-29 Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis

Publications (2)

Publication Number Publication Date
AU2016287200A1 AU2016287200A1 (en) 2018-01-18
AU2016287200B2 true AU2016287200B2 (en) 2020-09-17

Family

ID=53496506

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016287200A Active AU2016287200B2 (en) 2015-06-29 2016-06-29 Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis

Country Status (9)

Country Link
US (2) US10588926B2 (enExample)
JP (1) JP6837015B2 (enExample)
KR (1) KR102713511B1 (enExample)
CN (2) CN108076643B (enExample)
AU (1) AU2016287200B2 (enExample)
CA (1) CA2989977A1 (enExample)
MX (1) MX383921B (enExample)
RU (1) RU2758109C2 (enExample)
WO (1) WO2017001440A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2989977A1 (en) 2015-06-29 2017-01-05 Ferring B.V. Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
EP3427745A1 (en) 2017-07-12 2019-01-16 Nederlandse Organisatie voor toegepast- natuurwetenschappelijk onderzoek TNO New probiotic composition for prevention of bacterial vaginosis
CN108004188B (zh) * 2018-01-11 2020-02-14 广东龙创基药业有限公司 一种鼠李糖乳杆菌及其用于制备阴道抑菌药物的应用
RU2703708C1 (ru) * 2018-10-08 2019-10-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ прогнозирования степени риска нарушения микробиоты влагалища
AU2021284269A1 (en) 2020-06-01 2023-01-05 Ferring B.V. Vaginal microbiota compositions
ES2984142T3 (es) * 2020-06-11 2024-10-29 Adm Denmark As Composición probiótica y usos de la misma contra infecciones por Candida
ES2983665T3 (es) * 2020-07-14 2024-10-24 Probisearch S L U Cepa de Lactobacillus salivarus PS11610 y su uso en la prevención y el tratamiento de disbiosis del aparato urogenital
KR102546934B1 (ko) 2021-04-02 2023-06-23 대한민국 락토바실러스 람노서스 kcc-51 균주 및 이를 포함하는 조성물
CN113287753A (zh) * 2021-05-24 2021-08-24 国珍健康科技（北京）有限公司 一种用于改善女性阴道炎症的益生菌组合物
CN115252655B (zh) * 2022-07-14 2023-06-16 金华银河生物科技有限公司 用于改善阴道炎症的益生菌后生元制品及制备方法和应用
CN115569154B (zh) * 2022-09-21 2024-06-11 微康益生菌(苏州)股份有限公司 防治念珠菌阴道炎的鼠李糖乳杆菌LRa05及其应用
CN118077903B (zh) * 2024-03-27 2024-09-17 瀚天生物(北京)科技有限公司 一种用于女性改善阴道紧致和水润环境的口服益生菌复合制剂及其制备方法与应用
WO2025210272A1 (en) * 2024-04-05 2025-10-09 Ferring B.V. Composition comprising lactobacillus species for vaginal therapies

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012035028A1 (en) * 2010-09-14 2012-03-22 Hso Health Care Gmbh Compositions for the vaginal and oral administration of lactobacillus and uses thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8603338D0 (sv) 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan
FR2672300B1 (fr) * 1991-02-01 1994-09-23 Agronomique Inst Nat Rech Xylanase, souches de bacillus productrices de xylanase et leurs utilisations.
US5733568A (en) * 1993-12-03 1998-03-31 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
DE69802260T2 (de) * 1998-04-30 2002-07-04 Renata Maria Anna Cavaliere Vesely Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
KR20010101171A (ko) * 1998-12-11 2001-11-14 추후기재 비뇨생식기 감염의 치료 및 예방을 위한 락토바실러스의경구 투여
US20020044926A1 (en) * 1999-12-10 2002-04-18 Gregor Reid Oral administration of lactobacillus for the treatment and prevention of urogenital infection
SE521022C2 (sv) * 2001-09-20 2003-09-23 Ellen Ab Mjölksyraproducerande bakterier för användning som probiotiska organismer i vaginan hos människa
US20040022775A1 (en) * 2002-04-15 2004-02-05 Gregor Reid Methods of treating viral infections in mammals
US20090028839A1 (en) * 2004-12-23 2009-01-29 Tchikindas Mikhail L Compositions and methods for the prophylaxis and treatment of vaginal infections
ATE473636T1 (de) * 2005-02-15 2010-07-15 Barry R Goldin Nahrungsmittel mit probiotischem und isoliertem beta-glukan und verwendungsverfahren dafür
EP2206506A1 (en) * 2008-12-18 2010-07-14 Bracco Imaging S.p.A Probiotic formulations
EP2216036A1 (en) * 2009-02-10 2010-08-11 Nestec S.A. Lactobacillus rhamnosus NCC4007, a probiotic mixture and weight control
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
CN102835657B (zh) * 2011-06-20 2014-08-20 丰华生物科技股份有限公司 用以抑制发炎反应及抗阴道炎的含乳酸菌食品组合物及医药组合物
DK2836587T3 (en) * 2012-04-09 2017-05-08 Chr Hansen As Bioprotection using Lactobacillus rhamnosus strains
FR2992861B1 (fr) * 2012-07-09 2014-10-17 Probionov Utilisation de thiosulfate pour potentialiser l'effet anti-pathogene des lactobacilles
US20140234259A1 (en) * 2012-12-11 2014-08-21 Suzanah Juras Natural Intra-Vaginal Inserts to Control Imbalanced pH
CN103409334B (zh) * 2013-01-16 2018-07-20 生合生物科技股份有限公司 抑制阴道炎病原菌之乳酸杆菌及其用途
JP6110240B2 (ja) * 2013-04-10 2017-04-05 国立大学法人広島大学 乳酸菌の菌体等、並びにこれらを含有する口腔内疾患の予防材等及び食品
RU2570622C2 (ru) * 2013-10-24 2015-12-10 Автономная Некоммерческая Организация "Научно-Исследовательский Центр Биотехнологии Антибиотиков И Других Биологически Активных Веществ "Биоан" ШТАММ Lactobacillus rhamnosus, ОБЛАДАЮЩИЙ АНТИБАКТЕРИАЛЬНОЙ И АНТИГРИБКОВОЙ АКТИВНОСТЬЮ В ОТНОШЕНИИ ПАТОГЕННОЙ И УСЛОВНО-ПАТОГЕННОЙ ВАГИНАЛЬНОЙ МИКРОФЛОРЫ
CA2989977A1 (en) 2015-06-29 2017-01-05 Ferring B.V. Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012035028A1 (en) * 2010-09-14 2012-03-22 Hso Health Care Gmbh Compositions for the vaginal and oral administration of lactobacillus and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GREGOR REID et al., Selection of Lactobacillus Strains for Urogenital Probiotic Applications. JOURNAL OF INFECTIOUS DISEASES. JID, vol. 183, no. S1, 1 March 2001, pages s77-s80 *
KISS H et al., Vaginal Lactobacillus microbiota of healthy women in the late first trimester of pregnancy. JOURNAL OF OBSTETRICS AND GYNAECOLOGY, vol. 114, no. 11, 1 November 2007, pages 1402-1407 *
REID G et al., FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, vol. 35, 1 January 2003, pages 131-134 *
SHEETAL PITHVA et al., Probiotic Attributes of Autochthonous Lactobacillus rhamnosus Strains of Human Origin. APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 173, no. 1, 1 May 2014, pages 259-277 *

Also Published As

Publication number Publication date
US20180228850A1 (en) 2018-08-16
CN108076643B (zh) 2021-09-21
CN108076643A (zh) 2018-05-25
US10588926B2 (en) 2020-03-17
US20200268815A1 (en) 2020-08-27
JP2018520677A (ja) 2018-08-02
RU2017143465A (ru) 2019-08-01
CN113564075A (zh) 2021-10-29
KR102713511B1 (ko) 2024-10-04
US11202813B2 (en) 2021-12-21
WO2017001440A1 (en) 2017-01-05
AU2016287200A1 (en) 2018-01-18
KR20180021777A (ko) 2018-03-05
MX383921B (es) 2025-03-14
RU2017143465A3 (enExample) 2019-11-20
CA2989977A1 (en) 2017-01-05
JP6837015B2 (ja) 2021-03-03
MX2017016748A (es) 2018-11-09
RU2758109C2 (ru) 2021-10-26

Similar Documents

Publication Publication Date Title
US11202813B2 (en) Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
US8846027B2 (en) Compositions for the vaginal and oral administration of Lactobacillus and uses thereof
CN101160389B (zh) 对致病微生物的生长具有抑制能力和抗变应性作用的新的耐酸性沙克乳酸杆菌益生菌-65
WO2021114658A1 (zh) 动物双歧杆菌乳亚种i797、其分离纯化方法及应用
CN105567586A (zh) 一株具有抗糖尿病功能的植物乳杆菌及其应用
US20210275612A1 (en) Method for alleviating inflammation-related disorder
CN114752529B (zh) 植物乳杆菌hom3201菌株及其活菌制剂、制备方法和用途
CN104522648B (zh) 一种四联益生菌制剂及应用
CN104480032A (zh) 一株具有增强免疫活性的植物乳杆菌
CN116064313B (zh) 植物乳杆菌ccfm1281在缓解运动性疲劳中的应用
WO2025039454A1 (zh) 可调节肠道菌群的母乳源发酵粘液乳杆菌msjk0025及其应用
CN109929773A (zh) 一株可用于富硒培养的双歧杆菌及其活性蛋白和应用
CN117159598B (zh) 植物乳植杆菌Lp18在制备增强免疫的药物或保健食品方面的用途及产品
CN117165497A (zh) 一种改善便秘的植物乳植杆菌Lp18及其应用和产品
WO2025021206A1 (zh) 一种植物乳杆菌vb165及其应用
CN116555115A (zh) 一种植物乳杆菌nxu0011及其用途
CN117917475A (zh) 一种调节肠道菌群的植物乳植杆菌p16及其应用、产品和方法
CN113005067A (zh) 多功能复合益生菌制剂及其制备方法
CN116889578A (zh) 一种具有抗过敏功效的肠膜明串珠菌肠膜亚种的菌株或菌剂的用途
TWI764295B (zh) 加氏乳桿菌tci943或其代謝產物及其用於改善肌膚狀況的用途
KR20240132177A (ko) 항이상지질혈증 활성을 갖는 신규 락티플란티바실러스 플란타룸 균주 및 이의 용도
EP3313424B1 (en) Lactobacillus rhamnosus bacterium for treatment of e.g. bacterial vaginosis
CN118580982A (zh) 副干酪乳杆菌ty-f15及其应用
CN116515676A (zh) 一种调节肠道炎性反应的副干酪乳杆菌e10
CN119855897A (zh) 使用共生组合物来抗鼠伤寒沙门杆菌感染的方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)